RPRX
$24.92
Revenue | $564.69Mn |
Net Profits | $543.99Mn |
Net Profit Margins | 96.33% |
Royalty Pharma Plc’s revenue jumped 5.29% since last year same period to $564.69Mn in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 5.1% jump in its revenue since last 3-months.
Royalty Pharma Plc’s net profit jumped 654.34% since last year same period to $543.99Mn in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 433.3% jump in its net profits since last 3-months.
Royalty Pharma Plc’s net profit margin jumped 616.44% since last year same period to 96.33% in the Q3 2024. On a quarterly growth basis, Royalty Pharma Plc has generated 407.4% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.93 |
EPS Estimate Current Year | 0.93 |
Royalty Pharma Plc’s earning per share (EPS) estimates for the current quarter stand at 0.93 - a -4.12% fall from last quarter’s estimates.
Royalty Pharma Plc’s earning per share (EPS) estimates for the current year stand at 0.93.
Earning Per Share (EPS) | 1.01 |
Dividend Per Share (DPS) | 0.21 |
Royalty Pharma Plc’s earning per share (EPS) jumped 27.85% since last year same period to 1.01 in the Q3 2024. This indicates that the Royalty Pharma Plc has generated 27.85% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Royalty Pharma Plc declared 0.21 dividend per share during the earnings announcement for Q3 2024.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2024-05-09 | 0.98 | 0.98 | 0% |
2024-08-08 | 0.97 | 0.96 | -1.03% |
2024-11-06 | 0.93 | 1.01 | 8.6% |